BioSpace News Archive

Teva Pharmaceutical Industries Ltd. reported results for the quarter ended September 30, 2019..

Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced that the Aptose management team will participate in the 25th Annual International BIO-Europe Partnering Conference, being held November 11th -13th in Hamburg, Germany. Aptose will be presenting and hosting 1x1 meetings.

KEVEYIS®(dichlorphenamide) Achieved $5.7 Million in Revenue Along with a Positive Contribution Margin in Third Quarter of 2019; Strongbridge Remains On-Track to Meet or Exceed the Top End of Full-Year KEVEYIS Revenue Guidance of $18 Million to $20 Million

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today reported financial results for the third quarter of 2019 and recent business highlights.

Arcturus Therapeutics (NASDAQ: ARCT, the “Company”), a leading messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases, today announced that the Company is expanding its platform to include STARR (Self-Transcribing And Replicating RNA) technology™ for human and animal health vaccine applications.

21st China Hi-Tech Fair (CHTF2019) will be held on November 13-17, 2019

Partnership backed by robust clinical evidence, showing value of an integrated approach to infection prevention

The FAST score is a simple combination of two physical biomarkers: liver stiffness by Vibration Controlled Transient Elastography and Controlled Attenuation Parameter together with aspartate aminotransferase, a circulating biomarker.

The announcement was made during the American Medical Writer’s Association annual conference in San Diego, California.

At the Extra General Meeting held in Biotage AB (Reg. No. 556539-3138) on November 7, 2019, the following resolutions were passed, among others.